Premium
Changes in metabolic parameters following a switch to aripiprazole in Japanese patients with schizophrenia: One‐year follow‐up study
Author(s) -
Takeuchi Hiroyoshi,
Uchida Hiroyuki,
Suzuki Takefumi,
Watanabe Koichiro,
Kashima Haruo
Publication year - 2010
Publication title -
psychiatry and clinical neurosciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.609
H-Index - 74
eISSN - 1440-1819
pISSN - 1323-1316
DOI - 10.1111/j.1440-1819.2009.02036.x
Subject(s) - aripiprazole , qt interval , schizophrenia (object oriented programming) , medicine , psychology , triglyceride , psychiatry , endocrinology , cholesterol
The purpose of the present study was to evaluate changes in metabolic parameters after switching to aripiprazole in Japanese population. In this 1‐year observation study, following a switch to aripiprazole, 32 patients with schizophrenia were observed and assessment was done of bodyweight, total cholesterol, triglyceride, serum prolactin level, and corrected QT (QTc) interval. Significant reductions were observed in these parameters other than QTc interval. Given known detrimental metabolic and hormonal effects of some atypical antipsychotics, a switch to aripiprazole may warrant serious consideration also in Asian patients who suffer those side‐effects.